首页> 外文OA文献 >350P Rheumatologic immune related adverse events (irAEs) secondary to immune checkpoint inhibitor (ICI) therapy: A Western Australia experience

【2h】

350P Rheumatologic immune related adverse events (irAEs) secondary to immune checkpoint inhibitor (ICI) therapy: A Western Australia experience

机译：350p的风湿病免疫相关不良事件（IRAES）继发于免疫检查点抑制剂（ICI）治疗：西澳大利亚州的经验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
A. Khan; H. Martin; M. Khattak;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. P3.01-04 Immune Checkpoint Inhibitors (ICIs) in NSCLC: Immune Related Adverse Events (irAEs) and Outcomes. A Canadian Single Institution Experience [J] . B. Basulaiman, A. Robinson, W. Hopman, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P3.01-04免疫检查点抑制剂（ICIS）在NSCLC：免疫相关不良事件（IRAES）和结果。加拿大单一机构经验
2. 637?Immune-related adverse events (irAEs) may indicate a favorable prognosis in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI) [J] . Dylan Martini, Sean Evans, Subir Goyal, Journal for ImmunoTherapy of Cancer . 2020,第Suppla3期

机译：637？免疫相关的不良事件（伊拉克）可能表明用免疫检查点抑制剂（ICI）治疗的转移性肾细胞癌（MRCC）患者的良好预后
3. Rheumatologic Immune-related Adverse Events Associated with Immune Checkpoint Inhibitor Therapy in Cancer Care: A Case Series from an Academic Center [J] . Roberts Janet, Oswald Anna, Cusnir Ina, The Journal of rheumatology . 2018,第7期

机译：风湿病免疫相关不良事件与免疫检查点抑制剂治疗癌症护理：一个学术中心的案例系列
4. ENGINEERING AND PRE-CLINICAL EVALUATION OF A HUMAN ENZYME IMMUNE CHECKPOINT INHIBITOR FOR CANCER THERAPY [C] . Everett Stone, John Blazek, Christos Karamitros, Enzyme Engineering Conference . 2018

机译：癌症治疗人酶免疫检查点抑制剂的工程与临床评价
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy [O] . Vivek Kumar, Neha Chaudhary, Mohit Garg, 2017

机译：免疫检查点抑制剂治疗引起的免疫相关不良事件（irAEs）的当前诊断和管理
7. P3.01-04 Immune Checkpoint Inhibitors (ICIs) in NSCLC: Immune Related Adverse Events (irAEs) and Outcomes. A Canadian Single Institution Experience [O] . K. Virik, B. Basulaiman, A. Robinson, 2018

机译：P3.01-04免疫检查点抑制剂（ICIS）在NSCLC：免疫相关不良事件（IRAES）和结果。加拿大单一机构经验

350P Rheumatologic immune related adverse events (irAEs) secondary to immune checkpoint inhibitor (ICI) therapy: A Western Australia experience

著录项

相似文献

相关主题

期刊订阅